Abstract:The incidence of metabolic disorders, such as obesity and type two diabetes (T2DM), continues to increase worldwide, and their onset is often attributed to adherence to a western diet and a sedentary lifestyle. However, large variability exists in one's likelihood of developing metabolic dysregulation, illustrating that our understanding of heritability patterns remains poorly understood. Diabetes and obesity are multifactorial diseases, and their onset is influenced by both genetic and environmental factors. Genome-wide association studies report a number of alterations in the coding sequence associated with the onset of T2DM and obesity. However, these genes explain only a fraction of the cases, leaving the majority unaccounted for. The missing heritability question implies that other factors are responsible for the onset and development of the disease. Given that the developing fetus is susceptible to the maternal environment, a growing body of evidence demonstrates that maternal metabolic characteristics as well as disruptions to the prenatal environment may induce long-term genetic, phenotypic, and physiologic adaptations in the developing fetus, which could have a permanent effect on its future health. This phenomenon is known as developmental programming and is mediated through epigenetic modifications, which include modulation of gene expressions that do not alter the original deoxyribonucleic (DNA) sequence. Epigenetic modifications are capable of changing gene expression in metabolism-related genes and are accomplished through DNA methylation, histone acetylation, and ribonucleic acid (RNA) mechanisms. In this review, we discuss maternal metabolic factors, such as obesity, dyslipidemia, and gestational diabetes (GDM) that lead to epigenetic changes in the offspring and predispose future generations to metabolic abnormalities. We will also describe the association between maternal lifestyle factors and exposure to toxins with epigenetic modulations in the offspring. Lastly, we will provide a brief review of the possibility of using epigenetics as potential interventions and therapeutic modalities to help in early diagnosis and prevention of metabolic disorders.

Fetal programming of obesity and type 2 diabetes

Molecular mechanisms involved in fetal programming and disease origin in adulthood

Long-term Outcomes and Potential Mechanisms of Offspring Exposed to Intrauterine Hyperglycemia

Early-life Programming of Type 2 Diabetes Mellitus: Understanding the Association between Epigenetics/Genetics and Environmental Factors

Early programming of glucose–insulin metabolism

Developmental programming of health and disease

Epigenetic Programming and Fetal Metabolic Programming

Programming of weight and obesity across the lifecourse by the maternal metabolic exposome: A systematic review

Neurodevelopmental Programming of Adiposity: Contributions to Obesity Risk

Maternal Metabolic Health, Lifestyle, and Environment - Understanding How Epigenetics Drives Future Offspring Health

Maternal obesity as a risk factor for developing diabetes in offspring: An epigenetic point of view

Transgenerational Transmission of Non-communicable Diseases: How to Break the Vicious Cycle?

Neurodevelopmental Pathways to Obesity and Type 2 Diabetes: Insights From Prenatal Exposure to Maternal Obesity and Gestational Diabetes Mellitus: A Report on Research Supported by Pathway to Stop Diabetes

Animal Foetal Models of Obesity and Diabetes - From Laboratory to Clinical Settings

Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia

The fetal programming of food preferences: current clinical and experimental evidence

Origins of obesity in the womb: Fetal adiposity and its determinants

Developmental programming of offspring adipose tissue biology and obesity risk

Gestational Diabetes Mellitus, Programing and Epigenetics

Prenatal programming of postnatal endocrine responses by glucocorticoids

Maternal Diabetes and Fetal Programming Toward Neurological Diseases: Beyond Neural Tube Defects